Future studies using conditional NKG2D-deficient mice will help dissect the function of each NKG2D-expressing cell type and determine which ones act as tumour promoters, as tumour suppressors and which cells demonstrate a dual functionality over time, as we predict for CD8+ T effector cells. Here, KLRK1 is linked to neoplasm.